Enbrel Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Condition:   Ankylosing Spondylitis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Condition:   Ankylosing Spondylitis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Condition:   Ankylosing Spondylitis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Condition:   Ankylosing Spondylitis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Condition:   Ankylosing Spondylitis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Condition:   Ankylosing Spondylitis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Condition:   Ankylosing Spondylitis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Condition:   Spondyloarthrosis Intervention:   Drug: Etanercept Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials